OsteoStix

OsteoStix is a nutritional supplement and therapeutic adjunct developed by Anwerina Deutschland GmbH, containing a combination of calcium carbonate (providing 500 mg elemental calcium) and colecalciferol (1000 I.E. Vitamin D3). Formulated as a direct granulate that can be consumed without water, it is indicated for the prevention and treatment of combined calcium and vitamin D deficiencies, particularly in elderly populations, and as a supplemental treatment alongside specific osteoporosis therapies. The mechanism of action involves providing essential calcium for bone matrix formation and Vitamin D3 to facilitate intestinal calcium absorption and regulate bone mineralization through the Vitamin D receptor.

Brand names

OsteoStixCalcium Vitamin D3 500 mg/1000 I.E. OsteoStix Direktgranulat

Other names

Calcium carbonate + CholecalciferolCalciumcarbonat + Colecalciferol